Categories Analysis, Industrials

Allegiant (ALGT) may continue to take a hit from travel changes brought on by COVID-19

The company expects significant capacity cuts in May and June due to lower leisure demand trends

Like its peers in the airline industry, Allegiant Travel Company (NASDAQ: ALGT) was hit badly by the coronavirus pandemic. The company reported a 9.4% drop in operating revenues and a 42% decline in adjusted EPS. The numbers were reportedly better than what analysts had forecasted.

The company saw a slowdown in demand at the end of February followed by a sharp drop by mid-March. March revenues were down 40% year-over-year.

Based on a report by IATA, global passenger demand in 2021 is expected to be 24% below 2019 levels. The report also states that 2019 levels are not expected to be exceeded until 2023. If restrictions continue, leading to a delay in the opening of economies, global revenue passenger kilometers (RPK) in 2021 could be 34% lower than 2019 levels.   

In January, Allegiant reported a nearly 12% increase in capacity year-over-year along with a slight increase in load factor while in February, capacity rose 20.5% but load factor dipped by 1.5 points. In March, capacity fell by over 12% while load factor declined over 27 points. For the first quarter, capacity increased 4%.

Allegiant reports Q1 2020 earnings results

Allegiant reduced its April capacity by 87.4% and the company expects significant capacity cuts in May and June due to lower leisure demand trends. However, on its quarterly conference call, the company said it believes leisure travel is more likely to get back on track faster compared to international and business travel. Allegiant added that it has been seeing a slight pickup in leisure travel in recent weeks.

The company has seen a slight uptick in bookings in select markets over the past couple of weeks corresponding to the opening of beaches in Florida. Allegiant believes the next step in demand recovery is dependent on the reopening of theme parks, casino resorts and NFL stadiums in Orlando and Las Vegas, which are two of the company’s largest summer travel destinations.

The company believes international and business travel could take more time to resume as most companies have adapted to remote work and web conferencing. This could reduce the need for business meetings and other work-related travel meaningfully. The company believes these shifts could lead to a structural change in the post COVID-19 business world. It can be assumed that reduced business travel could take a meaningful toll on the company and its airline peers.

Allegiant’s main competitor Spirit Airlines (NYSE: SAVE) reported its first quarter 2020 results last week and the company saw a sharp drop in passenger demand and bookings due to the pandemic-related restrictions. The airline reduced its April capacity by around 75% while the capacity for May and June was cut by approx. 95%.  

Allegiant, meanwhile, is preparing for the worst over the coming months. The company is planning to retire around 10-15 aircraft in order to save cash. It is also looking to park as many as 10 aircraft due to softness in demand. Allegiant has also halted the construction of the Sunseeker resort indefinitely and has decided not to put any more capital into the project for at least the next 18 months.

Allegiant’s shares have fallen 53% over the past three months. The stock was up 5% in afternoon hours on Wednesday.

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top